Skip to main content
Log in

MDC in CKD good value for money in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Lin E, et al. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study. PLOS Medicine : 27 Mar 2018. Available from: URL: https://doi.org/10.1371/journal.pmed.1002532

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MDC in CKD good value for money in the US. PharmacoEcon Outcomes News 800, 25 (2018). https://doi.org/10.1007/s40274-018-4844-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4844-z

Navigation